Frankfurt/Main (Germany), 17th September 2008. IonGate Biosciences GmbH announces the closing of a new annular of allotment amounting to EUR 1 million. The basic addition comes in as the new broker Hessen Kapital I GmbH joins in a bashful affiliation with IonGate and it will be acclimated for added amplification of the US business as able-bodied as for the access of the all-around commercialization of SURFE2R Technology (SURFace Electrogenic Event Reader).
After initializing its all-embracing business activities at the alpha of 2008, IonGate now advances on its way appear all-embracing bazaar positioning. Following the foundation of IonGate Biosciences Inc. in January, the alpha of a cooperation with the Japanese bell-ringer BRC in March and of a cardinal business affiliation with US-based aggregation ARTEL in June, IonGate’s next accomplish will follow: The aloft armamentarium will abutment IonGate’s US sales activities to accommodated the accretion appeal for the afresh launched SURFE2R Workstation 5000. Furthermore, the invested basic will advance the development of the technology belvedere and the SURFE2R artefact family.
Hessen Kapital is a armamentarium of the accompaniment of Hesse for Hessian medium-sized business to strenghten the companies’ disinterestedness base. Hessen Kapital joins as IonGate’s third investor, afterward Heidelberg Innovation and KfW.
About IonGate Biosciences GmbH
IonGate Biosciences GmbH develops, produces and markets avant-garde screening technologies to investigate transporters and is the common arch aggregation in this area.
Transporters are capital for the metabolic functions of the cell, advice processing in the absolute organism, and aswell play a axiological role in the bloom of humans. Due to their difficult beginning accessibility transporters are underrepresented in accepted biologic screening processes to date. For the aboriginal time, IonGate’s SURFE2R One and SURFE2R Workstation 500 accommodate awful absolute anatomic screening of transporters in higher-throughput and appropriately positions itself as a arch accomplice for the biologic industry. With its SURFE2R Workstation 500 IonGate has created a abstruse base for an automated and able-bodied analytic technique. The aggregation provides absolute arrangement solutions, encompassing disposables and reagents, as able-bodied as alone consulting services, which cover the architecture of customized applications.
IonGate Biosciences GmbH is a adventure basic financed biotechnology aggregation amid in Frankfurt/Main, Germany and Portland / Maine, USA. In accession to the capital financier and arch accomplice Heidelberg Innovation the KfW holds a pale in IonGate. The aggregation was accustomed in 2000 and currently employs added than 30 agents members.
Contact
Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone+49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net
Wolfgang Lerch
President
IonGate Biosciences Inc.
25 Bradley Drive
Westbrook, Maine 04092-2013
U.S.A.
phone:+1.207.591.6376
fax:+1.207.591.6377
email info@iongate.net
Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de
订阅：
博文评论 (Atom)
没有评论:
发表评论